DPP-4 inhibitors, GLP-1 receptor agonists
Hamasaki, A.; Inagaki, N.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 1): 654-661
2011
ISSN/ISBN: 0047-1852 PMID: 21766677 Document Number: 648917
Document emailed within 1 workday
Related Documents
Verburg, A.F.E.; van den Donk, M.; Wiersma, T. 2019: Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors Nederlands Tijdschrift Voor Geneeskunde 163Seiler, S.M.; Peluso, M.; Tuttle, J.G.; Pryor, K.; Klimas, C.; Matsueda, G.R.; Bernatowicz, M.S. 1996: Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists Molecular Pharmacology 49(1): 190-197
Johansen, P.A.; Chase, L.A.; Sinor, A.D.; Koerner, J.F.; Johnson, R.L.; Robinson, M.B. 1995: Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats Molecular Pharmacology 48(1): 140-149
Eriks, J.C.; van der Goot, H.; Timmerman, H. 1993: New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists Molecular Pharmacology 44(4): 886-894
Heinzl, S. 2006: Dipeptidylpeptidase IV inhibitors and dual action PPAR-agonists Medizinische Monatsschrift für Pharmazeuten 29(3): 93-96
Kohli, J.D. 1990: Dopamine receptor agonists and antagonists Proceedings of the Western Pharmacology Society 33: 21-27
Shannon, H.E.; Bemis, K.G.; Hendrix, J.C.; Ward, J.S. 1990: Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats Journal of Pharmacology and Experimental Therapeutics 255(3): 1071-1077
Krutetskaia, Z.I.; Lebedev, O.E.; Krutetskaia, N.I. 1998: Effect of inhibitors of mitochondrial oxidative metabolism on Ca-responses induced by purinergic agonists and thapsigargin in rat peritoneal macrophages Tsitologiia 40(1): 93-99
Maton, P.N.; Jensen, R.T. 1992: Use of gut peptide receptor agonists and antagonists in gastrointestinal diseases Gastroenterology Clinics of North America 21(3): 551-566
Sullivan, G.W. 2003: Adenosine A2A receptor agonists as anti-inflammatory agents Current Opinion in Investigational Drugs 4(11): 1313-1319
Villalón, C.M.; Terrón, J.A.; Hong, E.; Saxena, P.R. 1993: The cardiovascular effects of serotonin receptor agonists and antagonists (II) Archivos del Instituto de Cardiologia de Mexico 63(6): 553-561
Miklavc, A.; Kocjan, D.; Hadzi, D.; Mavri, J.; Koller, J. 1989: Binding of agonists and antagonists to beta-adrenergic receptor Progress in Clinical and Biological Research 291: 275-280
Unger, J. 2018: A Clinical Overview of Once-weekly Glucagon-like Peptide-1 Receptor Agonists Journal of Family Practice 67(6 Suppl): S1-S2
Gende, O.A.; Camilión de Hurtado, M.C.; Cingolani, H.E. 1985: Effect of pH changes on the binding of agonists and antagonists to the adrenergic beta receptor Acta Physiologica et Pharmacologica Latinoamericana: Organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y de la Asociacion Latinoamericana de Farmacologia 35(2): 205-216
Perrone, R.; Berardi, F.; Bettoni, G.; Tortorella, V. 1988: Dopamine receptor agonists: new angularly annulated tricyclic compounds Il Farmaco; Edizione Scientifica 43(1): 61-69
Sippl, W.; Stark, H.; Höltje, H.D. 1998: Development of a binding site model for histamine H3-receptor agonists Die Pharmazie 53(7): 433-437
Woolverton, W.L.; Goldberg, L.I.; Ginos, J.Z. 1984: Intravenous self-administration of dopamine receptor agonists by rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 230(3): 678-683
Liao, R.M.; Chang, Y.H. 2001: Different effects of 5-HT receptor agonists on operant response in rats under DRL 10-s and DRL 30-s schedules Proceedings of the National Science Council Republic of China. Part B Life Sciences 25(4): 223-232
Belcheva, S.; Petkov, V.D.; Konstantinova, E.; Petkov, V.V.; Boyanova, E. 1995: Effects on nociception of the Ca2+ and 5-HT antagonist dotarizine and other 5-HT receptor agonists and antagonists Acta Physiologica et Pharmacologica Bulgarica 21(4): 93-98
Wu, J.M.; Nitecki, D.E.; Biancalana, S.; Feldman, R.I. 1996: Discovery of high affinity bombesin receptor subtype 3 agonists Molecular Pharmacology 50(5): 1355-1363